Annah S. Rolig

Also affiliated with Providence Portland Medical Center

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Combining bempegaldesleukin (CD122-preferential IL-2 pathway agonist) and NKTR-262 (TLR7/8 agonist) improves systemic antitumor CD8+ T cell cytotoxicity over BEMPEG+RT”.

Combining bempegaldesleukin (CD122-preferential IL-2 pathway agonist) and NKTR-262 (TLR7/8 agonist) improves systemic antitumor CD8+ T cell cytotoxicity over BEMPEG+RT

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2021-004218

N/A

0.965DataRank · unranked

31 citations

Daniel C Rose, Grace Helen McGee, Werner Rubas, Saul Kivimäe, William L. Redmond +1 more

NKTR-214 immunotherapy synergizes with radiotherapy to stimulate systemic CD8+ T cell responses capable of curing multi-focal cancer

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2019-000464

N/A

0DataRank · unranked

31 citations

Annah S. Rolig, Deborah H. Charych, Ute Hoch, Melissa J. Kasiewicz, Daniel C Rose +4 more

Enhancing clinical and immunological effects of anti-PD-1 with belapectin, a galectin-3 inhibitor

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-002371

N/A

0DataRank · unranked

99 citations

Yoshinobu Koguchi, Rom S. Leidner, Annah S. Rolig, Elizabeth R. Sturgill, Zhaoyu Sun +15 more